Tag Archives: PLT

Top 5 Low Price Stocks To Invest In 2018

The recent earning announcement on May 31, 2017 created sudden fear in the public’s mind and brought the stock price of Michael Kors (NYSE:KORS) down by around 9% in one day. As of this writing, the price remains at $33. In this article, I will discuss one negative and five positives, and explain why you should consider buying the stock at this low price.

One Negative

One negative, but a big one, that dragged down the stock price was the earning disappointment mainly driven by the macroeconomic situations in retail sector.

The entire retail sector has faced strong headwinds in recent years due to the emergence of online retailers (predominantly Amazon (NASDAQ:AMZN)), a strong dollar and a reduced number of tourists shopping in the U.S. The affected companies include Macy’s (NYSE:M), JCPenny (NYSE:JCP), Coach (NYSE:COH), Michael Kors, etc. The negative trends have driven down the stock price of the affected companies significantly in recent years, and the concern is legitimate in general,

Top 5 Low Price Stocks To Invest In 2018: Affimed N.V.(AFMD)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Affimed NV (NASDAQ: AFMD) were down around 21 percent to $1.70. Affimed priced its public offering of 10,000,000 of its common shares at $1.80 per common share.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares rose 47.1 percent to $3.22 in pre-market trading after jumping 54.23 percent on Wednesday.
    Digital Power Corporation (NYSE: DPW) rose 27.6 percent to $0.800 in pre-market trading after gaining 9.79 percent on Wednesday.
    Social Reality Inc (NASDAQ: SRAX) shares rose 23.1 percent to $7.16 in the pre-market trading session after surging 37.59 percent on Wednesday.
    China Auto Logistics Inc (NASDAQ: CALA) rose 16.9 percent to $4.15 in pre-market trading after gaining 4.11 percent on Wednesday.
    Riot Blockchain Inc (NASDAQ: RIOT) rose 15.1 percent to $18.40 in pre-market trading after climbing 42.01 percent on Wednesday.
    Seven Stars Cloud Group Inc (NASDAQ: SSC) rose 14.5 percent to $2.85 in the pre-market trading session after gaining 0.40 percent on Wednesday.
    Affimed NV (NASDAQ: AFMD) shares rose 14.3 percent to $2.40 in pre-market trading after gaining 4.88 percent on Wednesday.
    Corecivic Inc (NYSE: CXW) rose 10.2 percent to $25.56 in pre-market trading after climbing 0.65 percent on Wednesday.
    LM Funding America, Inc. (NASDAQ: LMFA) rose 9.6 percent to $3.30 in pre-market trading after surging 34.98 percent on Wednesday.
    U.S. Global Investors, Inc. (NASDAQ: GROW) rose 7.2 percent to $3.30 in pre-market trading after dropping 8.06 percent on Wednesday.
    Xunlei Ltd (NASDAQ: XNET) rose 6.8 percent to $25.61 in pre-market trading after climbing 11.74 percent on Wednesday.
    Net 1 UEPS Technologies Inc (NASDAQ: UEPS) shares rose 5.9 percent to $13.00 in pre-market trading after gaining 21.34 percent on Wednesday.
    Addus Homecare Corporation (NASDAQ: ADUS) rose 5.5 percent to $35.60 in pre-market trading after gaining 3.69 percent on Wednesday.
    TOP SHIPS Inc (NASDAQ: TOPS) rose 5.2 percent to $0.528 in pre-market trading after falling 10.36 percent on Wednesday.
    Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) rose 4.7 percent to $14.11 in pre-market trading. Teva Pharma

Top 5 Low Price Stocks To Invest In 2018: Shire plc(SHPG)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Specialty pharmaceuticals Shire (SHPG) and Mallinckrodt (MNK) soared today following their better-than-expected earnings, while Morgan Stanley worried about Valeant Pharmaceutical International’s (VRX) ability to sell its unwanted assets.

  • [By Jim Robertson]

    That’s why its worth pointing out that just yesterday, small cap cannabinoid prodrug pharmaceutical stock Vitality Biopharma, Inc. (OTCQB: VBIO) announced the appointment of Tracy Rockney, J.D. to the position of Senior Regulatory Advisor. In addition to being the Co-Founder & Chief Operating Officer of OneSource Regulatory, a regulatory consulting firm, Rockney was previously:

    From May 2010 to May 2015, she was the VP, Regulatory Affairs at AbbVie Inc (NYSE: ABBV) leading the executive functions related to regulatory policy and intelligence. From August 1993 to January 2005, she held positions of increasing responsibility with Pfizer Inc (NYSE: PFE), formerly Wyeth.  From January 2005 to April 2010, she held positions with Shire PLC (NASDAQ: SHPG), including serving as Senior Director, Regulatory Affairs. This included responsibilities as Therapeutic Area Head for Shire’s Gastrointestinal Business Unit, Regulatory Advertising & Promotion and CMC. Rockney led the regulatory team and negotiations with the FDA for LIALDA which are part of the drug class of aminosalicylates that are now part of the clinical standard-of-care for treating inflammatory bowel disease. LIALDA™ was found to be effective in Phase 3 trials for inducing remission of active mild-to-moderate ulcerative colitis after eight weeks of treatment. LIALDA™ (also now marketed as Mezavant®) had 2016 U.S. sales of $714 million – up 16% relative to 2015 sales.

    Rockney’s work for Shire is of particular interest to Vitality Biopharma which has developed a new class of cannabinoid prodrugs (medications or compounds that, after administration, are converted within the body into a pharmacologically active drug), known as cannabosides, which upon ingestion can enable the selective delivery of THC and cannabidiol (CBD) to the gastrointestinal tract. Cannabosides could provide therapeutic benefits for infl

  • [By Max Macaluso and David Williamson]

    At the end of last week, a Bloomberg article revealed that Shire (NASDAQ: SHPG  ) and pharmaceutical giant Sanofi (NYSE: SNY  ) may be circling ViroPharma (NASDAQ: VPHM  ) . The the following video, from The Motley Fool’s health care show Market Checkup, analysts David Williamson and Max Macaluso take a close look at ViroPharma and discuss the recent interest in this small biotech company.

  • [By Ben Levisohn]

    We highlight the key takeaways below, which have read-throughs for brand drug companies we cover such asAllergan (AGN), Shire (SHPG), Valeant Pharmaceuticals International, Mallinckrodt,Endo International and Jazz Pharmaceuticals (JAZZ), among others.

Top 5 Low Price Stocks To Invest In 2018: iShares MSCI All Peru Capped ETF (EPU)

Advisors’ Opinion:

  • [By Andrew Efimoff] Related Some Positive Indexing News For A Frontier Markets ETF Why The Frontier Markets ETF Slumped Last Year Status Quo Decisions Would Bode Well For PAK ETF (Seeking Alpha)
    Related EPU Peru ETF Confronts Politics Commodities Call For The Colombia ETF Graċ¸½a Y Montero May Have Peaked In 2016 (Seeking Alpha) Gainers Pakistan: Global XMSCI Pakistan ETF (NYSE: PAK) is up 5.67 percent after receiving MSCI’s Emerging Markets Index approval. Peru: iShares MSCI All Peru Capped Index Fund(NYSE: EPU) is up 2.15 percent after Kuzynski won Peru’s nail-biting election. Philippines: iShares MSCI Philippines Investable(NYSE: EPHE) is up 2.21 percent after Macquarie Research said President Elect Rodrigo Duterte would lift the Pilipino property market. India: iShares MSCI India ETF (NYSE: INDA) is up 1.96 percent after India’s government relaxed regulation, making it easier for domestic airlines to fly overseas.

    Related Link: Some Positive Indexing News For A Frontier Markets ETF

  • [By Todd Shriber, ETF Professor]

    ARGT, the lone exchange traded fund dedicated to Argentine equities, is up 19.6 percent year-to-date. That is good for the second-best showing among Latin America single-country ETFs, trailing only the iShares MSCI Capped Peru Index Fund (NYSE: EPU).

Top 5 Low Price Stocks To Invest In 2018: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top 5 Low Price Stocks To Invest In 2018: Utilities Select Sector SPDR ETF (XLU)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    The Dow utility average ended last week at a stabilizing 639.95 after trading as low as 616.19 on Nov. 14. Keep in mind that a “death cross” was confirmed on election day, when the 50-day simple moving average fell below the 200-day simple moving average, indicating that lower prices are likely ahead. The 200-day is now at 666.30. The utility average has returned to my range of key levels of 635.23 and 670.81, which remain magnets for the remainder of 2016. This week’s value level is above the Nov. 14 low at 620.87. Investors seeking the safety of dividends can trade the Utilities Select Sector SPDR Fund (XLU) , which is a basket of 28 utility stocks.

  • [By WWW.MONEYSHOW.COM]

    With a little more than $6 billion in assets and average daily trading volumes in excess of 12 million shares per day, SPDR Utilities (XLU) is the top choice to hold during Utilities seasonally favorable period. It has a gross expense ratio of just 0.14% and comes with the added kicker of a 3.37% dividend yield.

  • [By Craig Jones]

    Speaking on Bloomberg Markets, Kevin Kelly of Recon Capital Partners suggested that investors with a long position in Utilities SPDR (ETF) (NYSE: XLU) should consider an options strategy that offers protection ahead of the FOMC meeting.

  • [By Craig Jones]

    On CNBC's Options Action, Dan Nathan suggested a bearish options trading idea in Utilities SPDR (ETF) (NYSE: XLU).

    The stock caught his attention, because he noticed a big put options volume last week in the name. He thinks traders should not be in the stock ahead of a possible rate hike.

great stocks

We noted earlier that Valeant Pharmaceuticals International (VRX) has popped today after selling assets for more than $2 billion, beginning what many expect to be just the first round of such sales. BMO’s Gary Nachman notes that Valeant had received “a solid price” for its assets. He explains:

The first transaction is the sale of Dendreon (Provenge) to Sanpower Group for $820mn in cash. Provenge is a treatment for prostate cancer and is not core to Valeant; thus, we are not surprised by this asset sale. We estimate Provenge sales of $306mn for 2016, which translates to a multiple of ~2.7x.Valeant has been struggling to accelerate Provenge since it acquired the product, and given that the company does not have a real oncology presence we think this deal makes a lot of sense.

The second transaction is the sale of CeraVe, AcneFree and AMBI to L’Oreal for $1.3bn in cash. These products are OTC skincare brands that we believe are core to Valeant’s dermatology/OTC business; thus, this deal is more surprising to us. However, with annual combined sales for the three products of $168mn, that translates to a multiple of ~7.7x. We think that is a good price and demonstrates Valeant’s willingness to part with some core assets if the valuation makes sense. We view that as a smart business decision given the urgency forValeant to pay down its significant $30bn debt level more aggressively…

great stocks: Kate Spade & Company(KATE)

Advisors’ Opinion:

  • [By Steve Symington]

    Shares of Kate Spade & Company (NYSE:KATE) fell 25.1% in the month of April,according to data provided byS&P Global Market Intelligence, after reports that the luxury lifestyle-products specialist wanted more time to consider a buyout offer, then announced disappointing first-quarter 2017 results.

  • [By Lisa Levin]

    Kate Spade & Co (NASDAQ: KATE) was down, falling around 14 percent to $19.60 after it was reported the company would spend more time to negotiate the Coach Inc (NYSE: COH) offer.

  • [By Ben Levisohn]

    Kate Spade (KATE) caught a bounce on Wednesday when the Wall Street Journalreported that it was actively seeking a buyer. Since then, we’ve learned that the fashion accessories retailer looks set to auction itself off to the highest bidder, with the process potentially beginning next month, with bidders potentially including Coach (COH) and Michael Kors (KORS). In a note today, SunTrust Robinson Humphrey analystPamela Quintiliano and team contend that Kate Spade could fetch as much as $23 a share:

    Getty Images

    Looking at recent historical deals, we arrive at a $18-$23 potential deal range. We analyzed transactions that have been announced over the past four years and involved companies catering to a higher income customer. These deals include Southern Tide (acquired by Oxford Industries (OXM)), Joe’s Jeans (acquired by Sequential Brands Group (SQBG)), prAna (acquired by Columbia Sportswear (COLM)), The Jones Group (acquired by Sycamore Partners [private] and Juicy Couture (acquired by Authentic Brands Group [private]). The average EV/EBITDA multiple of these transactions are 12.9x (in line with KATE’s 5-year historical average of 12.1x) and implies a potential deal range of $22-$23. When taking the average of recent (F13-16) deals implies an ~10.5x EV/EBITDA multiple. When applying the ~10.5x multiples to KATE’s trailing EBITDA, we arrive at an $18- $19 potential share price.

    Shares of Kate Spade have gained 1.1% to $18.70 at 2:08 p.m. today, while Coach has declined 0.2% to $34.95, Michael Kors is little changed at $42.86, Oxford Industries has fallen 0.7% to $60.38, Columbia Sportswear has climbed 1.4% to $58.60, and Sequential Brands Group has jumped 3.7% to $4.77.

  • [By Ben Levisohn]

    Time, time, time. See what’s become of Kate Spade (KATE), as investors look around at its possibilities…and don’t like what they see. That’s the takeaway today following Kate Spade’s earnings release, and update on a potential takeover.

    Getty Images

    Kate Spade reported a profit of 1 cent a share, missing forecasts for 7 cents, on sales of $271.2 million, well below analyst expectations for $299 million. And Kate Spade also updated investors on its efforts to sell itself, without offering much of an update at all.

    Cowen’s Oliver Chen and team still expect a deal to happen but lower the probability of a deal occurring to 70% from 80%. They explain why:

    …formal language on deal prospects articulates process is proceeding in a timely manner with no definitive timetable and no assurance that process will result in a transaction. We still expect a deal to happen, but do lower our probability from 80% to 70% given the likelihood that potential buyer(s) and KATE have not agreed on a clearing price in earlier rounds of negotiation. We believe a bidder such as Coach (COH) does not want to overpay, is disciplined about managing ROIC, and returns and synergies split may be more rational at an offer price in the range of $22-25. We continue to believe KATE has a long global growth runway ahead with opportunities for store growth abroad, further expansion into non-handbag categories, and supply + digital synergy potential…We rate KATE Market Perform and lower our price target to $21 (was $27). Our updated valuation is based on ~10x our FY18E adj. EBITDA or $284mm.

    Investors, however, want to see a deal get done: Shares of Kate Spade have tumbled 6.6% to $18.12 at 3:26 p.m. today, while Coach has declined 0.5% to $39.51, and Michael Kors (KORS), also rumored to be interested in an acquisition, has fallen 1.1% to $36.92.

  • [By Ben Levisohn]

    Coach (COH) rose to the top of the S&P 500 today after reports that Kate Spade (KATE) had put itself up for sale caused shares of fashion-accessory retailers to rise.

  • [By Ben Levisohn]

    Ever since peaking in late April, Kate Spade’s (KATE) shares have been in a downward spiral so pronounced that even an amateur technical analyst like myself could draw its trend line lower. Today, however, its shares are soaring after the Wall Street Journal reported that Kate Spade was actively seeking a buyer.

    Getty Images

    Mizuho’s Betty Chen and Alex Pham run the math on a possible acquisition price:

    When we examined historical transactions in the specialty retail sector, we noticed a wide range of valuations. Select relevant transactions to consider would be ~2x EV/Sales Coach (COH) paid for Stuart Weitzman, Samsonites acquisition of Tumi at 14x EV/EBITDA, 13x EV/EBITDA for Joseph A. Banks by Mens Wearhouse (TLRD) and Kerings acquisition of Volcom for 18x EV/EBITDA. We believe potential valuation could be as high as ~2x EV/ Sales and ~14x EV/EBITDA given Kate Spade’s unique growth profile to expand to ~$4bn in revenue (from $1.4bn in FY16) and improving profitability from 12% EBIT margin TY to at least HTeens-LDD, in our view (Coach is 18.7% and Michael Kors (KORS) is 21.3%). On these two metrics, Kate Spade would be valued at $21-23…

    We believe the growth profile coupled with the brands unique appeal to Millennials and broad-based success across categories ranging from handbags to apparel and jewelry could be attractive to many buyers, including Coach, which was rumored to be evaluating the company in recent weeks.

    The news has sent shares of Kate Spade soaring: They’re up 24% at $18.03 at 2:11 p.m., a gain that has turned this year’s 18% loss as of last night into a 2% gain during afternoon trading.

    The move has also put a dent in Kate Spade’s downtrend (and now you’ll see my amateur technical analysis abilities at work):

    FactSet

    That’s one way to break a downtrend.

great stocks: (CVKEY)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    Another illustration of the excellent project structuring skills that First Sponsor’s management possesses relates to the divestment of a 70% interest in its property development project in China, the Star of East River project in Dongguan to Chinese property developer China Vanke (OTC:CVKEY) in FY2016. It recorded a disposal gain of S$97.3 million in 4QFY2016 and recouped its capital investment in its entirety with a surplus cash return of approximately S$23.2 million. More importantly, First Sponsor still retains exposure to the Star of East River project with a 30% interest while having a brand-name listed property developer like China Vanke leading the project.

  • [By SEEKINGALPHA.COM]

    On December 14, 4-Traders reported “BYD signed a strategic partnership agreement” with China Vanke (OTC:CVKEY), China’s largest property developer. The partnership will integrate Vanke’s property development and BYD’s cloud rail, providing a solution for urban development. BYD is also partnering (with 42 others) in a 5G joint innovation center with China Mobile (NYSE:CHL).

  • [By SEEKINGALPHA.COM]

    For example, Evergrande Life – a unit of property developer China Evergrande Group (OTC:EGRNF) – saw its premiums increase more than 40-fold in 2016. It used the proceeds to accumulate a significant stake in rival developer China Vanke (OTC:CVKEY) last year.

great stocks: LightPath Technologies, Inc.(LPTH)

Advisors’ Opinion:

  • [By Lisa Levin]

    LightPath Technologies, Inc. (NASDAQ: LPTH) shares dropped 24 percent to $2.86 following fiscal 2018 first quarter results. Net income for the quarter was around $218,000, versus $140,000 in the year-ago quarter.

  • [By Jim Robertson]

    Today, our Under the Radar Moversnewsletter suggestedshorting small cap optical solutions manufacturing stockLightPath Technologies (NASDAQ: LPTH) in our short term portfolio:

great stocks: NXP Semiconductors N.V.(NXPI)

Advisors’ Opinion:

  • [By WWW.KIPLINGER.COM]

    The chipmaker has agreed to acquire NXP Semiconductors NV (NXPI) for $110 a share, or about $39 billion. That’s more than worth it for what NXP brings to the table.

  • [By Sreekanth Anasa]

    A recent Reuter’s report suggests that the San Diego, California basedchipmaker is all set to win a conditional Japanese antitrust go-ahead for its multi-billion dollar NXP Semiconductor (NASDAQ:NXPI) deal. Earlier, Bloomberg reported that Qualcomm may win European Union approval for its NXPacquisition by the year-end with slight modifications to the concessions. The smartphone chip giant reportedly seems to have struck a deal with the European regulatory body by agreeing to drop certainstandard essential and system-level patents belonging to NXP in the proposed takeover. EU anti-trust body has now set the new deadline fordeciding on Qualcommsacquisition of NXP asMarch 5, 2018. If Bloomberg reports turn out to be true, this could be shot in the arm for Qualcomm which at the moment is trying to fend off the takeoverfrom Broadcom. If EU approval goes through then other remainingregulatory bodies will soon fall in line.

  • [By Sreekanth Anasa]

    While Qualcomm continues to work on closing its $47 billion acquisition of automotive chipmaker NXP Semiconductor (NSDQ:NXPI), at the CES 2017, NXP showcased why the company is a major force in automotive computing.At the show, NXP partnered with several companies to demonstrate a “collective vision of safe and secure end-to-end mobility through a highly automated driving demonstration and experience.” NXP also demonstratedits so-called RoadLINK platform in collaboration with automotive parts giant Delphiand privately held start-up Savari, highlighting the traffic safety improvements one can achieve through the platform.

  • [By Sreekanth Anasa]

    Qualcomm (NASDAQ:QCOM) stock price has now fallen below the crucial 20-day, 50-day and 100-day moving averages. Its legal issues have again weighed heavy on QCOM stock of late. QCOM stock has a crucial support at the $52.66 level, which is just below the last closing price (on April 13). Qualcomm stock has not fallen below these levels in 2017.A fall below this level means QCOM stock could drop, moving close to itsone-year lows. However, two popular momentum indicators Bollinger Bands and Relative Strength Index (RSI) indicators suggest that QCOM stock is oversold. The technicals depict mixed scenario for QCOM stock. QCOM stock has lost momentum going into its Q2 earnings, with the stock losing more than 5% in the last 5 trading sessions and is still down more than 10.5% YTD. QCOM stock still makes a good long-term investment, especially with the $47B NXP Semiconductor (NASDAQ:NXPI) acquisition lined up. The smartphone chipset maker’s stock is also named the top dividend stock with insider buying and has adividend yield of 4.27%. Long-term investors with a high-risk appetite might relish buying QCOM stock at such low levels. However, it would be prudent for risk-averse investors to stay on the sidelines till the Q2 earnings, which would give a better picture of Qualcomm’s present legal woes and its future implications.

great stocks: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

stock market exchange

1. Gulf in crisis: Stocks in Qatar plummeted as much as 8% on Monday amid a major diplomatic crisis in the Gulf.

Saudi Arabia, Bahrain, the United Arab Emirates, Egypt and Yemen all said they had cut diplomatic ties with Qatar over claims that it supports terrorism. Qatar says the move is “unjustified.”

The first wave of economic fallout was immediate: Etihad, Emirates and FlyDubai announced they are halting all flights in and out of Doha, the Qatari capital, starting Tuesday morning.

Uncertainty in the oil-rich region helped boost energy prices. U.S. crude futures gained 0.6% to trade just below $48 per barrel.

2. London terror attack: Britain was getting back to business on Monday after the country suffered its third terror attack in less than three months. Seven people were killed in a brazen assault in central London late Saturday.

Prime Minister Theresa May has said that a crucial general election scheduled for Thursday will go ahead as planned.

stock market exchange: Technology Select Sector SPDR ETF (XLK)

Advisors’ Opinion:

  • [By ]

    What My System Flagged As A Buy This Week
    It’s no secret that the technology sector has had an incredible year so far — the SPDR Technology Select ETF (NYSE: XLK) is up over 31% year-to-date, compared with the S&P 500’s 14% return.

  • [By Wayne Duggan]

    High-flying tech stocks were hammered Wednesday, sending the Technology Select Sector SPDR Fund (NYSE: XLK) down more than 2.5 percent and the Nasdaq down 1.4 percent, its worst day of trading since August 17.

  • [By Money Morning News Team]

    If the price is keeping you out of GOOGL, take a look at theTechnology SPDR ETF (NYSE Arca: XLK), where you get to hold shares of many of these top tech companies at a fraction of the cost.

  • [By Elizabeth Balboa]

    For now, SPDR S&P Retail (ETF) (NYSE: XRT) and Financial Select Sector SPDR Fund (NYSE: XLF) investors can enjoy more than 6.5-percent five-day gains bolstered by PowerShares QQQ Trust, Series 1 (ETF) (NASDAQ: QQQ)’s 1.8-percent and Technology Select Sector SPDR Fund (NYSE: XLK)’s 2.7-percent concessions.

stock market exchange: First Majestic Silver Corp.(AG)

Advisors’ Opinion:

  • [By Jim Robertson]

    There is no denying that some silver stocks have a problem with the problem beingthe focus on silver. On Monday, some key silver stocks like First Majestic Silver Corp (NYSE: AG) along with solver benchmark the iShares Silver Trust ETF (NYSEARCA: SLV) saw sharper than normal selloffs on an otherwise short trading day. The problem for investors in First Majestic Silver Corp is that its probably the closest thing to a pure play silver stock out there as most other silver miners have long since made aneffort to diversify into gold and other preciousmetals in case silver prices fall off.

  • [By Lisa Levin] Related CXW Trump Or Clinton: Who Would Create More Jobs? The 2016 Economics Nobel Prize Winner's Case Against Private Prisons: Contracts Are The Key Wall Street Breakfast: Trump Takes The White House (Seeking Alpha)
    Related SAEX 20 Biggest Mid-Day Losers For Friday 22 Stocks Moving In Friday's Pre-Market Session SAExploration wins $35M seismic data deal (Seeking Alpha)
    Gainers
    Corrections Corp Of America (NYSE: CXW) shares rose 16.3 percent to $16.50 in pre-market trading following Donald Trump's victory.
    SAExploration Holdings, Inc. (NASDAQ: SAEX) shares rose 15.4 percent to $7.26 in pre-market trading after the company reported a new $35 million deep water ocean-bottom marine project award.
    The GEO Group Inc (NYSE: GEO) shares rose 12.9 percent to $26.95 in pre-market trading following Donald Trump's victory.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 12.3 percent to $7.40 in pre-market trading after gaining 0.30 percent on Tuesday.
    Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) rose 11.7 percent to $10.35 in pre-market trading. Ariad Pharmaceuticals disclosed that its Phase 1/2 trial data on investigational drug brigatinib were published in The Lancet Oncology.
    AK Steel Holding Corporation (NYSE: AKS) rose 11.2 percent to $6.75 in pre-market trading after gaining 3.23 percent on Tuesday.
    Pretium Resources Inc (NYSE: PVG) rose 11 percent to $10.50 in pre-market trading after declining 1.66 percent on Tuesday.
    First Majestic Silver Corp (NYSE: AG) rose 9.3 percent to $8.90 in the pre-market trading session. First Majestic reported Q3 earnings of $0.07 per share on revenue of $79.3 million. Silver futures gained 2.2 percent to $18.77 an ounce.
    Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) rose 9.2 percent to

stock market exchange: Microchip Technology Incorporated(MCHP)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Microchip Technology (MCHP) sunk to the bottom of the S&P 500 today as semiconductor stocks got clobbered.

    Getty Images

    Shares of Microchip Technology tumbled 7.5% to $61.23 today, while the S&P 500 declined 0.4% to 2,191.08. The SPDR S&P Semiconductor ETF (XSD) fell 4.8% to $52.29, while the VanEck Vectors Semiconductor ETF (SMH) dropped 4.8% to $67.68.

    Today’s slaughter comes two days after Microchip Technology narrowed its third-quarter guidance. Stifel’s Kevin Cassidy and team had the details:

    Microchip upwardly revised its December ending quarter…Non-GAAP EPS guidance was updated to $0.87 – $0.94 compared to $0.85 – $0.95 previously…The According to management, the upside is coming from better than expected integration of recent acquisitions. Management pointed out that significant gross margin improvements may be recognized as the inventory of higher cost products from the now closed Micrel fab is depleted. We have revised our revenue and non-GAAP earnings estimates and increased our 12-month target price to $70.

    Microchip Technology’s market capitalization fell to $13.2 billion from $14.3 billion yesterday. It report net income of $324 million on sales of $2.2 billion in fiscal 2016.

     

  • [By Ben Levisohn]

    My colleague Tiernan Rey at Barron’s Tech Trader Daily quoted B. Rileys Craig Ellis in a post today, who called the selloff yesterday an unusually attractive entry opportunity forApplied Materials andMicrochip Technology (MCHP) buyers.

stock market exchange: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top Tech Stocks To Buy For 2018

AMD Stock Looks Unstoppable Ahead Of Today’s Zen CPU Preview

Shares of Sunnyvale, California-based AMD (NSDQ:AMD)seem to be shaking off every threat to make new highs each passing day. While multiple technical indicators suggest that AMD stock is overbought right now, the stock has continued to move higher on the back of multiple positive triggers. Armed with multiple price target hikes and Radeon Instinct, a deeper foray in the machine learning space, AMD stock looks unstoppable going into today’s Zen CPU preview, despite the reported concerns over GPU ‘inventory pile ups’.

No Threat Seems Large Enough For AMD Stock Right Now Should you worry about GPU inventory pile ups? Probably Not

Pacific Crestanalyst Michael McConnell recently opined that there were dark clouds forming for Nvidia and AMD, as GPU inventory had started piling up for both chipmakers. As per McConnell, lower than expected demand or sell through of desktop graphics cards was leading to these pile ups, to the extent that it was also impacting prices of some of Nvidia’s high end graphics cards. Quoting from a post on Barron’s:

Top Tech Stocks To Buy For 2018: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

Top Tech Stocks To Buy For 2018: Virtusa Corporation(VRTU)

Advisors’ Opinion:

  • [By Lisa Levin]

    Technology shares gained around 0.85 percent in trading on Friday. Meanwhile, top gainers in the sector included Virtusa Corporation (NASDAQ: VRTU), and Ceragon Networks Ltd (NASDAQ: CRNT).

Top Tech Stocks To Buy For 2018: Wipro Limited(WIT)

Advisors’ Opinion:

  • [By Shanthi Rexaline]

    The industry — valued at over $150 billion and comprising companies such as Wipro Limited (ADR) (NYSE: WIT), Cognizant Technology Solutions Corp (NASDAQ: CTSH), Infosys Ltd ADR (NYSE: INFY) and Tata Consultancy Services — has thus far been competing effectively on certain unique selling propositions such as low-cost technology skills and high quality manpower.

Top Tech Stocks To Buy For 2018: Qualstar Corporation(QBAK)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Thursday, our Under the Radar Moversnewsletter suggestedpreemptively shorting small cap data storage systems stockQualstar Corporation (NASDAQ: QBAK):

  • [By Lisa Levin]

    Qualstar Corporation (NASDAQ: QBAK) was down, falling around 16 percent to $6.99. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 million.

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggestedshorting small cap data storage systems stock Qualstar Corporation (NASDAQ: QBAK):

    Quelstar is essentially a mirror image of Pixelworks. That is, it’s not just the bearish undertow we want to tap into here. It’s the failure of QBAK to follow-through on today’s effort to break above the 100-day moving average line with today’s early effort. The market dared the bulls to play their hand, and as it turns out, they were bluffing. The sheer scope of the reversal bar in the meantime today confirms the downtrend.

  • [By Lisa Levin] Related CRMD Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher 12 Biggest Mid-Day Gainers For Tuesday CorMedix's (CRMD) CEO Khoso Baluch on Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    Related BIOA Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher Mid-Morning Market Update: Markets Edge Higher; Tiffany Earnings Top Estimates BioAmber (BIOA) Q4 2016 Results – Earnings Call Transcript (Seeking Alpha)
    CorMedix Inc. (NYSE: CRMD) shares fell 27.5 percent to $1.50 after the company reported Q4 results and issued a business update.
    Bioamber Inc (NYSE: BIOA) shares tumbled 23.6 percent to $2.40. BioAmber reported FY16 adjusted loss of $1.07 per share on revenue of $8.3 million.
    The Medicines Company (NASDAQ: MDCO) shares dipped 20.9 percent to $41.62.
    Innocoll Holdings PLC (NASDAQ: INNL) shares fell 20.3 percent to $1.49. Innocoll posted a narrower-than-expected quarter loss, but revenue missed estimates. Stifel Nicolaus downgraded Innocoll from Buy to Hold.
    Rosetta Genomics Ltd. (USA) (NASDAQ: ROSG) shares declined 20.3 percent to $3.83. On Thursday, Rosetta Genomics disclosed a 1-for-12 reverse stock split.
    Esperion Therapeutics Inc (NASDAQ: ESPR) shares dropped 19.9 percent to $23.76. Esperion Therapeutics shares have jumped 106.19 percent over the past 52 weeks, while the S&P 500 index has gained 16.70 percent in the same period.
    AmTrust Financial Services Inc (NASDAQ: AFSI) tumbled 18.3 percent to $17.65. AmTrust Financial disclosed that it will delay its annual report filing for the fiscal year ended December 31, 2016.
    Qualstar Corporation (NASDAQ: QBAK) slipped 17.7 percent to $6.85. Qualstar reported a Q4 loss of $0.20 per share on revenue of $2.2 milli

Top Tech Stocks To Buy For 2018: Oclaro, Inc.(OCLR)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    Shares of optical component companies have dropped today, includingOclaro (NASDAQ:OCLR), Acacia (NASDAQ:ACIA), Lumentum (NASDAQ:LITE), and Finisar (NASDAQ:FNSR), whose shares were down 11%, 11%, 6%, and 3%, respectively, as of 3:30 p.m. EDT, after the U.S. broadened its investigation regarding compliance with sanctions programs.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Friday's regular session.

  • [By Arie Goren]

    Advanced Micro Devices, Inc.(NSDQ:AMD)had been by far the best performer in 2016 among all the 413 Russell 3000 tech stocks. Its stock price appreciation of 295.1% in 2016 was significantly higher than the second ranked tech stock NVIDIA Corporation (NVIDIA (NSDQ:NVDA)which gained 223.8% and the third-ranked stock Oclaro Inc. (NSDQ:OCLR)which was up 157.2% in 2016.

  • [By Peter Graham]

    Small cap fiber-optic networking product Applied Optoelectronics (NASDAQ: AAOI), a potential peer of EMCORE Corporation (NASDAQ: EMKR), Finisar Corporation (NASDAQ: FNSR) and Oclaro Inc (NASDAQ: OCLR), is thefifth mostshorted stock on theNASDAQ with short interest of 47.69% according to Highshortnterest.com.

investment options

U.K. stocks rose for the first time in five sessions on Monday, lifted by shares of energy and mining giants as oil prices gained and data showed a rebound in Chinas manufacturing activity.

The FTSE 100 index
UKX, +0.53%
gained 0.4% to 7,342.37, after ending at the lowest level since early May on Friday.

investment options: Cott Corporation(COT)

Advisors’ Opinion:

  • [By Dan Moskowitz]

    Cott (NYSE: COT  ) produces and sells over 200 different types of beverages in over 50 countries, and it implements a highly effective strategy. Cott is what is known as a Fast Follower, which makes it unique to other beverage companies.

investment options: Plantronics Inc.(PLT)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Plantronics Inc (NYSE: PLT) were down 25 percent to $33.36. Plantronics reported better-than-expected third-quarter earnings, but the company’s revenue missed analysts’ expectations. The company announced a new 1 million share buyback plan and issued a weak earnings forecast for the fourth quarter.

investment options: Open Text Corporation(OTEX)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    One split announcement came from OpenText Inc. (OTEX) — a stock we had already added to our portfolio back in July, 2014; it has since done very well.

investment options: Ameresco, Inc.(AMRC)

Advisors’ Opinion:

  • [By Manikandan Raman]

    There also some lesser known clean energy stocks that may witness downward movement on potential Trump win on negative sentiment. They include Pattern Energy Group Inc (NASDAQ: PEGI), Enviva Partners LP (NYSE: EVA), TerraForm Global Inc (NASDAQ: GLBL), Renewable Energy Group Inc (NASDAQ: REGI) and Ameresco Inc (NYSE: AMRC).

  • [By Lisa Levin]

    Shares of Ameresco Inc (NYSE: AMRC) got a boost, shooting up 16 percent to $6.05 after the company reported strong Q4 results.

    Navigator Holdings Ltd (NYSE: NVGS) shares were also up, gaining 23 percent to $13.50 on better-than-expected quarterly earnings.

  • [By Jason Hall]

    WhenAmeresco Inc(NYSE:AMRC) reported financial and operating results for its fourth quarter and fiscal year 2016 on March 2, the market was ecstatic, pushing shares up more than 17% on a combination of beating analyst expectations for profits, a solid order backlog for future business, and continued optimism around infrastructure investment in coming years.

investment options: America’s Car-Mart Inc.(CRMT)

Advisors’ Opinion:

  • [By Monica Gerson]

    America’s Car-Mart, Inc. (NASDAQ: CRMT) is projected to post its quarterly earnings at $0.58 per share on revenue of $149.13 million.

    Ryanair Holdings plc (ADR) (NASDAQ: RYAAY) is expected to report its quarterly earnings at $0.24 per share on revenue of $1.16 billion.

  • [By Monica Gerson]

    Analysts are expecting America’s Car-Mart, Inc. (NASDAQ: CRMT) to have earned $0.58 per share on revenue of $149.13 million in the latest quarter. America’s Car-Mart shares rose 2.06 percent to close at $23.25 on Friday.